Oligo-heparin action on endogenous glycosaminoglycans. Pharmacokinetics: direct and mediated effects.
Bergonzini
G
G
OPOCRIN S.p.A. Research Laboratories, Corlo (Modena), Italy.
Parma
B
B
Liverani
L
L
Prete
A
A
Mascellani
G
G
Bianchini
P
P
D000818:Animals; D003871:Dermatan Sulfate / Q000378:metabolism; D006025:Glycosaminoglycans / Q000378:metabolism*; D006495:Heparin, Low-Molecular-Weight / Q000097:blood / Q000493:pharmacokinetics*; D006497:Heparan Sulfate / Q000378:metabolism; D007084:Iliac Vein; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D051381:Rats; D017207:Rats, Sprague-Dawley
D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006495:Heparin, Low-Molecular-Weight; D006497:Heparan Sulfate